Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells.

de la Roche M, Worm J, Bienz M.

BMC Cancer. 2008 Jul 15;8:199. doi: 10.1186/1471-2407-8-199.

2.

Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades.

Katoh M, Katoh M.

Cancer Biol Ther. 2006 Sep;5(9):1059-64. Epub 2006 Sep 4. Review.

PMID:
16940750
3.

TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.

Brantjes H, Barker N, van Es J, Clevers H.

Biol Chem. 2002 Feb;383(2):255-61. Review.

PMID:
11934263
4.

Colorectal cancer and genetic alterations in the Wnt pathway.

Segditsas S, Tomlinson I.

Oncogene. 2006 Dec 4;25(57):7531-7. Review.

PMID:
17143297
5.

The Yin-Yang of TCF/beta-catenin signaling.

Barker N, Morin PJ, Clevers H.

Adv Cancer Res. 2000;77:1-24. Review.

PMID:
10549354
6.

A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.

Prosperi JR, Goss KH.

Curr Drug Targets. 2010 Sep;11(9):1074-88. Review.

PMID:
20545611
7.

Wnt signaling inside the nucleus.

Shitashige M, Hirohashi S, Yamada T.

Cancer Sci. 2008 Apr;99(4):631-7. doi: 10.1111/j.1349-7006.2007.00716.x. Epub 2008 Jan 2. Review.

8.

Emergence of TNIK inhibitors in cancer therapeutics.

Yamada T, Masuda M.

Cancer Sci. 2017 Feb 16. doi: 10.1111/cas.13203. [Epub ahead of print] Review.

Supplemental Content

Support Center